EPIC-XS supports all European member states and associated countries as well as International laboratories (in a more limited capacity). The user may not reside in the country where he/she has requested access to specific proteomic technology. Exceptions will be made with respect to generic scientific applications, where national access is allowed.
Austria
Belgium
Bulgaria
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Ireland
Italy
Latvia
Lituania
Luxemburg
Malta
Netherlands
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Association to Horizon 2020 is governed by Article 7 of the Horizon 2020 Regulation. Legal entities from Associated Countries can participate under the same conditions as legal entities from the Member States. Association to Horizon 2020 takes place through the conclusion of an International Agreement.
Albania
Armenia
Bosnia & Herzegovina
Croatia
Faroe Islands
Georgia
Iceland
Isreal
Liechtenstein
Macedonia
Moldova
Montenegro
Norway
Serbia
Switzerland
Tunisia
Turkey
Ukraine